-- The members of the Advisory Committee voted 12-2 for an approval of
-- Both lixisenatide and iGlarLixi for the treatment of type 2 diabetes were
discussed at the Advisory Committee meeting. The FDA had not requested a
vote on lixisenatide
-- FDA regulatory decisions on lixisenatide and iGlarLixi are expected in July
and August 2016, respectively
-- Zealand reiterates its financial guidance for 2016, including expectations
of increasing royalt
AUCKLAND, New Zealand, May 25, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Massey University has chosen Axios Systems' service management software, assyst, to transform ICT service delivery management to enhance the learning experience for its on-campus and distance-learning communities.
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.